EcoDrugPlus

Aurora Kinase B

Ensembl ID : ENSFHEG00000014967
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSFHEG00000010689
Gene Symbol: LOC105917086
3 Cross references
196 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSFHEG00000016586
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSFHEG00000011606
Gene Symbol: BDKRB2
4 Cross references
182 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSFHEG00000004359
Gene Symbol: BDKRB2
1 Cross references
241 Possible Orthologues:

Breakpoint Cluster Region Protein

Ensembl ID : ENSFHEG00000005512
Gene Symbol: LOC105939804
3 Cross references
203 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b

Ensembl ID : ENSFHEG00000015619
Gene Symbol: LOC105925257
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSFHEG00000005314
Gene Symbol: LOC105939193
3 Cross references
180 Possible Orthologues:

Calcium Channel, Voltage-Dependent, N Type, Alpha 1b Subunit, A

Ensembl ID : ENSFHEG00000011557
Gene Symbol: CACNA1BA
1 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Alpha 2/delta Subunit 1a

Ensembl ID : ENSFHEG00000003995
Gene Symbol: CACNA2D1A
1 Cross references
230 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSFHEG00000015075
Gene Symbol: CASR
3 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSFHEG00000019778
Gene Symbol: CACNA2D2
3 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).